Clinical Trial Update: Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sorafenib before and after transarterial chemoembolization with doxorubicin and mitomycin C in unresectable hepatocellular car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)
• Mitomycin-C (mitomycin C)
• Nexavar (Sorafenib)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED